Tiny Antibodies to Prevent Artery Blockage
Development of a novel intracellular targeting nanobody that blocks Cx43-mediated pathological proliferation
This research aims to create special tiny antibodies, called nanobodies, that can enter cells to help prevent arteries from becoming blocked, especially after procedures like stent placement.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Virginia Polytechnic Inst and St Univ NIH-funded |
| Lab location | 1 site (Blacksburg, United States) |
| Project ID | NIH-11189632 on NIH RePORTER |
What this research studies
When arteries are damaged, such as during stent placement, cells in the blood vessel walls can grow too much, leading to new blockages. Current treatments often use general medications that can have side effects. Our approach focuses on designing unique nanobodies, which are small antibodies that can get inside cells. These nanobodies will target a specific protein interaction that causes these cells to overgrow, aiming to stop the thickening of artery walls and improve long-term outcomes for patients with cardiovascular disease.
Who could benefit from this research
Good fit: This early-stage research is foundational for future therapies that could benefit patients experiencing artery blockages or those at risk of stent failure due to cell overgrowth.
Not a fit: Patients without cardiovascular disease or those whose conditions are not related to the specific cell overgrowth targeted by this research would not directly benefit from this particular approach.
Why it matters
Potential benefit: If successful, this work could lead to new, more targeted treatments that prevent artery re-narrowing after procedures like stenting, potentially reducing the need for repeat interventions.
How similar studies have performed: This research explores a novel approach using nanobodies to target intracellular protein interactions, which is a relatively untested strategy for this specific problem.
Where this research is happening
Blacksburg, United States
- Virginia Polytechnic Inst and St Univ — Blacksburg, United States (Active)
Researchers
- Principal investigator: Johnstone, Scott R — Virginia Polytechnic Inst and St Univ
- Study coordinator: Johnstone, Scott R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.